抗栓治疗后消化道出血的现状及抗栓策略  

Current Characteristics and Anti-thrombotic Strategy of Gastrointestinal Hemorrhage after Anti-thrombotic Therapy

作　　者：王斯佳 王国兴[1] WANG Sijia;WANG Guoxing(Department of Emergency,Beijing Friendship Hospital of Capital Medical College,Beijing 100050,China)

机构地区：[1]首都医科大学附属北京友谊医院急诊科,北京100050

出　　处：《心血管病学进展》2020年第8期790-793,共4页Advances in Cardiovascular Diseases

摘　　要：消化道出血是急诊常见的急危重症之一.近年来为了防治心脑血管疾病,口服抗血小板或抗凝药物的患者不断增多,使抗栓治疗后消化道出血的患者增加.现就抗栓治疗后消化道出血流行病学、临床预后及防治策略进行综述.Gastrointestinal hemorrhage is one of common emergent clinical scenario.To prevent cardiovascular diseases,prescription of antiplatelet and anticoagulant therapy is significantly increased,and the number of patients with gastrointestinal hemorrhage is subsequently increased.This literature is to review the epidemiology,prognosis and treat strategy of gastrointestinal hemorrhage after antiplatelet and anticoagulant therapy.

关 键 词：抗栓治疗 消化道出血 现状 防治策略 

分 类 号：R573[医药卫生—消化系统]